Tiny biotech firm, ABVC BioPharma Inc., surged in U.S. pre-market trading amid increasing talks on trading social network StockTwits, according to a report by Bloomberg on Monday.
- The Fremont, California-based firm’s shares rose nearly 930% in pre-market trading before cutting off the surge to 200%.
- At the close of trading on Friday, the stock had a market capitalization of $68.1 million.
- The company has issued a filing for a $50 million mixed securities portfolio on Friday.
The biotech firm published restructuring of a joint venture the previous month and issued patent applications for medicines for treating depression and attention-deficit hyperactivity disorder in September. ABVC up +272.58%